Mankind Pharma schedules 35th AGM for August 4, 2026

Mankind Pharma has scheduled its 35th Annual General Meeting (AGM) for August 4, 2026, at 3:30 p.m. IST through video conferencing and other audio-visual means. The meeting will be conducted in compliance with the provisions of the Companies Act, 2013 and relevant circulars from the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The venue of the meeting shall be deemed to be the Registered Office of the Company.

The company has dispatched the notice of the AGM along with the Annual Report for the financial year 2025-26 to members by electronic mode. This distribution adheres to the applicable regulations and listing requirements, including the Ministry of Corporate Affairs General Circular No. 03/2025. Shareholders can access this information on the company’s official website and the websites of the stock exchanges.

Key Meeting Details

Detail	Information
Meeting Name	35th Annual General Meeting
Date	August 4, 2026
Time	03:30 p.m. IST
Mode	Video Conferencing / Other Audio-Visual Means
Financial Year	2025-26

The intimation was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer of Mankind Pharma Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.17%	-1.51%	+4.83%	+15.69%	+7.35%	+75.09%

Mankind Pharma management will attend IIFL's Invest India Conference and Capital Day 2026 in London on June 23 and June 24, 2026. The participation includes one-on-one and group meetings with investors. The company stated that no unpublished price sensitive information will be shared during the conference. The schedule is subject to change due to exigencies on either side.

Participation Details

The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer.